Publications by authors named "Stephane Pouderoux"

Claim this Profile
H
Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer.
Constance Delaby, Anas Al Herk, Christophe Hirtz, William Jacot, Maryline Laigre, Stéphane Pouderoux

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study.
Quentin Dominique Thomas, Mohamed Chaabouni, Anas Al Herk, Cesar Lefevbre, Sarah Cavaillon, Stéphane Pouderoux

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.
Zahra Eslami-S, Luis Enrique Cortés-Hernández, Léa Sinoquet, Ludovic Gauthier, Valentin Vautrot, Stéphane Pouderoux

Br J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients.
Gaia Griguolo, Vittoria Aldegheri, Michele Bottosso, Alice Pittaro, Francesca Caumo, Stéphane Pouderoux

Int J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study.
Michel Fabbro, William Jacot, Marta Jarlier, Séverine Guiu, Véronique D'Hondt, Stéphane Pouderoux

Cancer Rep (Hoboken)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort.
Ivica Ratosa, Nika Dobnikar, Michele Bottosso, Maria Vittoria Dieci, William Jacot, Stéphane Pouderoux

Int J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study.
Amélie Darlix, Laure Cayrefourcq, Stéphane Pouderoux, Nicolas Menjot de Champfleur, Alexis Bievelez

Clin Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual Suspects.
Fanny Leenhardt, Frédéric Fiteni, Ludovic Gauthier, Marie Alexandre, Séverine Guiu, Stéphane Pouderoux

Pharmaceutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant Chemotherapy.
Elodie Chartron, Nelly Firmin, Célia Touraine, Angélique Chapelle, Eric Legouffe, Stéphane Pouderoux

Nutrients· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.
Léa Sinoquet, William Jacot, Ludovic Gauthier, Stéphane Pouderoux, Marie Viala

Clin Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy.
Fanny Leenhardt, Marie Alexandre, Severine Guiu, Stephane Pouderoux, Melanie Beaujouin

Cancer Chemother Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer.
Marie Viala, Nelly Firmin, Célia Touraine, Stéphane Pouderoux, Manon Metge

BMC Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid chromatography-tandem mass spectrometric assay for the quantification of CDK4/6 inhibitors in human plasma in a clinical context of drug-drug interaction.
Fanny Leenhardt, Matthieu Gracia, Catherine Perrin, Claudia Muracciole-Bich, Bénédicte Marion, Stephane Pouderoux

J Pharm Biomed Anal· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.
William Jacot, Martine Mazel, Caroline Mollevi, Stéphane Pouderoux, Véronique D'Hondt

Clin Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
William Jacot, Florence Dalenc, Evelyne Lopez-Crapez, Leonor Chaltiel, Anna Durigova, Stéphane Pouderoux

Breast Cancer Res Treat· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Gaia Griguolo, Stephane Pouderoux, Maria Vittoria Dieci, William Jacot, Céline Bourgier

Oncologist· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
Akiko Chiba, Rachna Raman, Alexandra Thomas, Pierre-Jean Lamy, Marie Viala, Stephane Pouderoux

Clin Breast Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.
Mélodie Dell'Ova, Eléonora De Maio, Séverine Guiu, Lise Roca, Florence Dalenc, Stéphane Pouderoux

BMC Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer.
Haïdar Saadoun, Pierre-Jean Lamy, Simon Thezenas, Stéphane Pouderoux, Frédéric Bibeau

Future Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification.
Anna Durigova, Pierre-Jean Lamy, Simon Thezenas, Stephane Pouderoux, Frédéric Montels

Clin Chem Lab Med· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Iron metabolism in breast cancer: knowledge and future].
Anna Durigova, William Jacot, Stéphane Pouderoux, Sylvie Roques, Frédéric Montels

Ann Biol Clin (Paris)· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy.
William Jacot, Stéphane Pouderoux, Simon Thezenas, Angélique Chapelle, Jean-Pierre Bleuse

Breast Cancer Res Treat· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study.
Kais Aldabbagh, Stéphane Pouderoux, Lise Roca, Sylvain Poujol, Michel Fabbro

Breast Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications].
William Jacot, Stéphane Pouderoux, Frédéric Bibeau, Cristina Leaha, Marie-Christine Chateau

Bull Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.
William Jacot, Marie-Cécile Gerlotto-Borne, Simon Thezenas, Stéphane Pouderoux, Sylvain Poujol

BMC Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis